Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE)-Reference-Cited by-同舟云学术

Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE)

Published:2022-07 Issue: Volume:103 Page:106680
ISSN:1743-9191
Container-title:International Journal of Surgery
language:en
Short-container-title:International Journal of Surgery

Author:

Yan Xiaolong,Duan Hongtao,Ni Yunfeng,Zhou Yongan,Wang Xiaoping,Qi Haini,Gong Li,Liu Honggang,Tian Feng,Lu Qiang,Sun Jianyong,Yang Ende,Zhong Daixing,Wang Tao^ORCID,Huang Lijun,Wang Jian,chaoyang Wang ,Wang Yuanyong,Wan Zhiyi,Lei Jie,Zhao Jinbo,Jiang Tao

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Reference53 articles.

1. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors;Uhlenhopp;Clin. J. Gastroneterol.,2020

2. Overview of esophageal cancer;Abbas;Ann. Cardiothorac. Surg.,2017

3. Epidemiology of esophageal squamous cell carcinoma;Abnet;Gastroenterology,2018

4. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N. Engl. J. Med.,2012

5. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial;Yang;J. Clin. Oncol.,2018

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A narrative review on advances in neoadjuvant immunotherapy for esophageal cancer: Molecular biomarkers and future directions;International Journal of Cancer;2024-09-14

2. Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial;Cancer Communications;2024-09-02

3. Genetic testing of neoadjuvant therapy patients with esophageal cancer;Gene Reports;2024-09

4. Tislelizumab synergizes with surgery to augment the survival benefit in stage II-III non-small cell lung cancer;Discover Oncology;2024-08-31

5. Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center Study;Annals of Surgical Oncology;2024-08-23